Evidence map›Paper›PMID 41284099›Full record

ArticleMolecular neurobiology2025

Presence of Astrocytic S1R/5-HT1A Heterocomplex in the mPFC: A Putative Link to S1R Activation Mediated Faster Antidepressant-Like Effects.

Peng Ren, Jing-Ya Wang, Meng-Jie Xu, Han Ni, Shuang Zhang, Chen-Xing Yue, De-Yi Yang, Yun-Feng Li

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peng Ren *Academy of Military Medical Sciences, 100850, Beijing, People's Republic of China.
Jing-Ya Wang *Academy of Military Medical Sciences, 100850, Beijing, People's Republic of China. janew1993@163.com.
Meng-Jie XuBeijing Institute of Basic Medical Sciences, 100850, Beijing, People's Republic of China.
Han NiAcademy of Military Medical Sciences, 100850, Beijing, People's Republic of China.
Shuang ZhangBeijing Institute of Basic Medical Sciences, 100850, Beijing, People's Republic of China.
Chen-Xing YueAcademy of Military Medical Sciences, 100850, Beijing, People's Republic of China.
De-Yi YangAcademy of Military Medical Sciences, 100850, Beijing, People's Republic of China.
Yun-Feng LiAcademy of Military Medical Sciences, 100850, Beijing, People's Republic of China. lyf619@aliyun.com.

Funding

STI2030-Major Projects 2021ZD0200900
6 · The paper itself

Abstract

In the brain, sigma non-opioid intracellular receptor 1/serotonin 1A receptor (S1R/5-HT1A) heterocomplexes are primarily localized within neuronal networks and play a key role in mediating the faster antidepressant-like effects induced by S1R activation. Existing evidence further suggests that astrocytes in medial prefrontal cortex (mPFC) contribute to these S1R-triggered, accelerated antidepressant responses. To address this, the current study employed neurochemical and in vivo fiber photometry approaches to examine whether S1R/5-HT1A heterocomplexes exist in astrocytes and modulate astrocytic structure and function, and their potential behavioral consequences. Behavioral analyses demonstrated that combined administration of S1R agonist SA4503 (1.0 mg/kg, i.p.) and 5-HT1A receptor agonist 8-OH-DPAT (0.3 mg/kg, i.p.) elicited faster antidepressant-like responses, whereas 8-OH-DPAT alone at the tested dosage lacked intrinsic antidepressant activity. Utilizing in situ proximity ligation assay integrated with immunohistochemical labeling for astrocytic markers, S1R/5-HT1A heterocomplexes were identified within astrocytes of the hippocampus and mPFC. Subacute treatment with either SA-4503 alone or in combination with 8-OH-DPAT resulted in a significant elevation of these heterocomplexes in GFAP/S100β-positive cells, alongside an increase in astrocytic density, particularly within the mPFC. Pharmacological interventions further revealed that co-activation of S1R and 5-HT1A induced an enhanced astrocytic Ca

Indexed as

Antidepressive AgentsAstrocytesPrefrontal CortexReceptor, Serotonin, 5-HT1AReceptors, sigma8-Hydroxy-2-(di-n-propylamino)tetralinAnimalsBehavior, AnimalMaleMiceMice, Inbred C57BLSigma-1 Receptor8-Hydroxy-2-(di-n-propylamino)tetralinAntidepressive AgentsReceptor, Serotonin, 5-HT1AReceptors, sigmaSigma-1 ReceptorAstrocyteDepressionS1R/5-HT1A heterocomplexSigma non-opioid intracellular receptor 1

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.